Nykredit A S Takes Position in Amgen Inc. $AMGN
MarketBeat
Nykredit A S initiated a new position in Amgen Inc. by purchasing 135,233 shares valued at approximately $49 million in the second quarter. Institutional investors collectively own 76.5% of Amgen's stock, with other major firms also adjusting their stakes. Amgen reported strong quarterly earnings, exceeding analyst expectations, and maintains a quarterly dividend of $2.52 per share.
Read the full story
This is a short summary. The complete article is published by MarketBeat.
Headline and summary aggregated from public news feeds. For information only — not financial advice.